Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 7.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 88,379 shares of the financial services provider’s stock after purchasing an additional 5,970 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in CME Group were worth $24,359,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Webster Bank N. A. lifted its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares in the last quarter. Highline Wealth Partners LLC grew its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares in the last quarter. Trifecta Capital Advisors LLC raised its holdings in shares of CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after buying an additional 42 shares during the period. Ransom Advisory Ltd purchased a new stake in shares of CME Group during the 1st quarter valued at about $31,000. Finally, Westside Investment Management Inc. lifted its position in CME Group by 105.0% during the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 63 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Stock Performance
CME Group stock opened at $285.04 on Friday. CME Group Inc. has a 52 week low of $222.56 and a 52 week high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $102.79 billion, a P/E ratio of 27.62, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. The stock has a 50 day moving average of $267.33 and a 200-day moving average of $272.85.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.
Analyst Upgrades and Downgrades
Several analysts have issued reports on CME shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Raymond James Financial reduced their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. TD Cowen upped their target price on shares of CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research note on Thursday, October 23rd. Jefferies Financial Group lowered their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a report on Friday, October 10th. Finally, Oppenheimer boosted their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $287.65.
Check Out Our Latest Report on CME
Insider Buying and Selling at CME Group
In other news, Director William R. Shepard purchased 262 shares of the firm’s stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the purchase, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 14,043 shares of company stock valued at $3,791,486. Corporate insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- What Does Downgrade Mean in Investing?
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- What is a support level?
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
